As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.

Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.

Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of ...

Treasury Secretary Scott Bessent said talks with China had been “very productive.” Both countries agreed to cut “recipricol” ...

Wall Street’s major averages ended the week slightly lower on Friday, losing gains for the week amid renewed optimism about upcoming trade deals and economic partnerships with other countries. Week-to ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...